Stockreport

Arsanis Granted Key Patents for ASN100 Covering Cross-Neutralizing S. aureus Toxin Antibodies

Actelis Networks, Inc.  (ASNS) 
Last actelis networks, inc. earnings: 11/9 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.arsanis.com/investor-relations
PDF Patents strengthen Company’s intellectual property portfolio for its lead product candidate ASN100 which is designed to uniquely address Staphylococcus a [Read more]